BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 26338801)

  • 1. Genomic profiling of myeloma: the best approach, a comparison of cytogenetics, FISH and array-CGH of 112 myeloma cases.
    Rack K; Vidrequin S; Dargent JL
    J Clin Pathol; 2016 Jan; 69(1):82-6. PubMed ID: 26338801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Detection of the Cytogenetic Aberrations in Multiple Myeloma by Using Microrray Comparative Genomic Hybridization].
    Wang YF; Wang H; Xi LY; Zhang ZH; Wang J; Dong F; Ke XY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Oct; 26(5):1389-1395. PubMed ID: 30295256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic profiling of plasma cell disorders in a clinical setting: integration of microarray and FISH, after CD138 selection of bone marrow.
    Berry NK; Bain NL; Enjeti AK; Rowlings P
    J Clin Pathol; 2014 Jan; 67(1):66-9. PubMed ID: 23969274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic profiling of myeloid sarcoma by array comparative genomic hybridization.
    Deeb G; Baer MR; Gaile DP; Sait SN; Barcos M; Wetzler M; Conroy JM; Nowak NJ; Cowell JK; Cheney RT
    Genes Chromosomes Cancer; 2005 Dec; 44(4):373-83. PubMed ID: 16080198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic significance of cytogenetics and molecular profiling in multiple myeloma.
    Sawyer JR
    Cancer Genet; 2011 Jan; 204(1):3-12. PubMed ID: 21356186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiplex ligation-dependent probe amplification and fluorescence in situ hybridization are complementary techniques to detect cytogenetic abnormalities in multiple myeloma.
    Alpar D; de Jong D; Holczer-Nagy Z; Kajtar B; Savola S; Jakso P; David M; Kosztolanyi S; Kereskai L; Pajor L; Szuhai K
    Genes Chromosomes Cancer; 2013 Sep; 52(9):785-93. PubMed ID: 23720363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacterial artificial chromosome array-based comparative genomic hybridization using paired formalin-fixed, paraffin-embedded and fresh frozen tissue specimens in multiple myeloma.
    Lennon PA; Zhuang Y; Pierson D; Zhang X; Williams C; Perez C; Lin P
    Cancer; 2009 Jan; 115(2):345-54. PubMed ID: 19109814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequential analysis of chromosome aberrations in multiple myeloma during disease progression.
    Wu KL; Beverloo B; Velthuizen SJ; Sonneveld P
    Clin Lymphoma Myeloma; 2007 Jan; 7(4):280-5. PubMed ID: 17324335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic power of abnormal cytogenetics for multiple myeloma: a multicenter study in China.
    Lai YY; Huang XJ; Cai Z; Cao XS; Chen FP; Chen XQ; Chen BA; Fang MY; Feng JF; Fu WL; Guo HY; Hou M; Hou J; Hu Y; Hu XT; Hu XM; Huang LQ; Jin J; Li JY; Li J; Li W; Liang YM; Liu T; Liu QF; Liu YH; Mao P; Ouyang J; Qiu LG; Qiu L; Shao CK; Shi B; Song YP; Sun ZM; Wang QS; Wang C; Wang JM; Wang YS; Wang Z; Wu JB; Wu YX; Xia RX; Xue YQ; Yang BZ; Yang G; Yang ZL; Yu L; Yuan Z; Zhang S; Zhang Y; Zhao HG; Zhao L; Zhou DB; Zou SH; Zhu YF
    Chin Med J (Engl); 2012 Aug; 125(15):2663-70. PubMed ID: 22931972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The value of fluorescence in situ hybridization for the detection of 11q in multiple myeloma.
    González MB; Hernández JM; García JL; Lumbreras E; Castellanos M; Hernández JM; Fernández-Calvo J; Gutiérrez NC; San Miguel JF
    Haematologica; 2004 Oct; 89(10):1213-8. PubMed ID: 15477206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of De Novo and Rare Inherited Copy Number Variants in Children with Syndromic Congenital Heart Defects.
    Hussein IR; Bader RS; Chaudhary AG; Bassiouni R; Alquaiti M; Ashgan F; Schulten HJ; Al Qahtani MH
    Pediatr Cardiol; 2018 Jun; 39(5):924-940. PubMed ID: 29541814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of cytogenetic aberrations in two B lineage subpopulations in multiple myeloma patients analyzed by combination of whole-genome profiling and FISH.
    Smetana J; Dementyeva E; Kryukov F; Nemec P; Greslikova H; Kupska R; Mikulasova A; Ihnatova I; Hajek R; Kuglik P
    Neoplasma; 2014; 61(1):48-55. PubMed ID: 24195508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Prognostically Relevant Chromosomal Abnormalities in Routine Diagnostics of Multiple Myeloma Using Genomic Profiling.
    Kjeldsen E
    Cancer Genomics Proteomics; 2016; 13(2):91-127. PubMed ID: 26912802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting plasma cells improves detection of cytogenetic aberrations in multiple myeloma: phenotype/genotype fluorescence in situ hybridization.
    Slovak ML; Bedell V; Pagel K; Chang KL; Smith D; Somlo G
    Cancer Genet Cytogenet; 2005 Apr; 158(2):99-109. PubMed ID: 15796956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Fluorescence in situ hybridization on bone marrow smear in the detection of cytogenetic aberrations of multiple myeloma].
    Wang XW; Li JY; Chen LJ; Qian SX; Hong M; Qiao C; Zhang JF; Xu W; Lu H; Xu JR
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Oct; 17(5):1230-3. PubMed ID: 19840456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of comparative genomic hybridization and fluorescence in situ hybridization for molecular diagnostics in multiple myeloma.
    Liebisch P; Viardot A; Bassermann N; Wendl C; Roth K; Goldschmidt H; Einsele H; Straka C; Stilgenbauer S; Döhner H; Bentz M
    Br J Haematol; 2003 Jul; 122(2):193-201. PubMed ID: 12846886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can genome array screening replace FISH as a front-line test in multiple myeloma?
    Boneva T; Brazma D; Gancheva K; Howard-Reeves J; Raynov J; Grace C; Nacheva EP
    Genes Chromosomes Cancer; 2014 Aug; 53(8):676-92. PubMed ID: 24757046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular cytogenetic aberrations in patients with multiple myeloma studied by interphase fluorescence in situ hybridization.
    Chen L; Li J; Xu W; Qiu H; Zhu Y; Zhang Y; Duan L; Qian S; Lu H
    Exp Oncol; 2007 Jun; 29(2):116-20. PubMed ID: 17704743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytogenetics of multiple myeloma.
    Trcić RL; Skelin IK; Sustercić D; Planinc-Peraica A; Ajduković R; Haris V; Kusec R; Begović D
    Coll Antropol; 2010 Mar; 34(1):41-4. PubMed ID: 20432732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in cytogenetic characterization of multiple myeloma.
    Saxe D; Seo EJ; Bergeron MB; Han JY
    Int J Lab Hematol; 2019 Feb; 41(1):5-14. PubMed ID: 29971938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.